Abstract

 Preview

This document describes the particular clinical laboratory practice requirements to ensure the quality of detection, identification and quantification of microbial pathogens using nucleic acid amplification tests (NAAT).

It is intended for use by laboratories that develop, and/or implement and use, or perform NAAT for medical, research or health-related purposes. This document does not apply to the development of in vitro diagnostic (IVD) medical devices by manufacturers. However, it does include verification and validation of such devices and/or the corresponding processes when implemented and used by the laboratories.


General information 

  • Status
     :  Published
    Publication date
     : 2020-11
    Corrected version (en)
     : 2020-12
  • Edition
     : 1
    Number of pages
     : 39
  • Technical Committee
     : ISO/TC 212 Clinical laboratory testing and in vitro diagnostic test systems
  • ICS
     :
    11.100.01 Laboratory medicine in general

Sustainable Development Goals

This standard contributes to the following Sustainable Development Goal:

3
Good Health and Well-being

Buy this standard

Format Language
PDF + ePub
Paper
  • CHF166

Life cycle


Got a question?

Check out our FAQs

Customer care
+41 22 749 08 88

Opening hours:
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)

Keep up to date with ISO

Sign up to our newsletter for the latest news, views and product information.

  2. Store
  3. Standards catalogue
  4. ICS
  5. 11
  6. 11.100
  7. 11.100.01
  8. ISO 17822:2020